Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae

Journal of Medical Microbiology

Volumn 58, Issue 10, 2009, Pages 1303-1308

  Landman, David ^a   Bratu, Simona ^a   Quale, John ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; CARBAPENEM; CARBAPENEMASE; ERTAPENEM; IMIPENEM; OUTER MEMBRANE PROTEIN K 35; OUTER MEMBRANE PROTEIN K 36; PROTEIN ACRAB; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; DNA SEQUENCE; EPSILOMETER TEST; GENE EXPRESSION; KLEBSIELLA PNEUMONIAE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

BACTERIAL PROTEINS; BASE SEQUENCE; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; DNA PRIMERS; DNA, BACTERIAL; GENE EXPRESSION; GENES, BACTERIAL; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MOLECULAR SEQUENCE DATA; PORINS;

EID: 70349312522     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.012575-0     Document Type: Article

References (31)

1. Albertí, S., Rodríquez-Quiñones, F., Schirmer, T., Rummel, G., Tomás, J. M., Rosenbusch, J. P. & Benedí, V. J. (1995). A porin from Klebsiella pneumoniae: sequence homology, three-dimensional model, and complement binding. Infect Immun 63, 903-910.
2. Anderson, K. F., Lonsway, D. R., Rasheed, J. K., Biddle, J., Jensen, B., McDougal, L. K., Carey, R. B., Thompson, A., Stocker, S. & other authors (2007). Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol 45, 2723-2725.
3. Ardanuy, C., Liñares, J., Domínguez, M. A., Hernández-Allés, S., Benedí, V. J. & Martínez-Martínez, L. (1998). Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems. Antimicrob Agents Chemother 42, 1636-1640. (Pubitemid 28311554)
4. Bradford, P. A., Urban, C., Mariano, N., Projan, S. J., Rahal, J. J. & Bush, K. (1997). Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob Agents Chemother 41, 563-569. (Pubitemid 27098404)
5. Bratu, S., Landman, D., Haag, R., Recco, R., Eramo, A., Alam, M. & Quale, J. (2005a). Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City. Arch Intern Med 165, 1430-1435.
6. Bratu, S., Mooty, M., Nichani, S., Landman, D., Gullans, C., Pettinato, B., Karumudi, U., Tolaney, P. & Quale, J. (2005b). Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob Agents Chemother 49, 3018-3030. (Pubitemid 40917631)
7. Bratu, S., Brooks, S., Burney, S., Kochar, S., Gupta, J., Landman, D. & Quale, J. (2007). Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York. Clin Infect Dis 44, 972-975. (Pubitemid 46452064)
8. Cai, J. C., Zhou, H. W., Zhang, R. & Chen, G.-X. (2008). Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother 52, 2014-2018. (Pubitemid 351758537)
9. Cao, V. T. B., Arlet, G., Ericsson, B.-M., Tammelin, A., Courvalin, P. & Lanbert, T. (2000). Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration. J Antimicrob Chemother 46, 895-900. (Pubitemid 32000598)
10. CLSI (2006). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 7th edn. Approved Standard M7-A7. Wayne, PA: Clinical and Laboratory Standards Institute.
11. Crowley, B., Benedí, V. J. & Doménech-Sánchez, A. (2002). Expression of SHV-2 β-lactamase and reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased resistance to cephalosporins and carbapenems. Antimicrob Agents Chemother 46, 3679-3682. (Pubitemid 35192952)
12. Doménech-Sánchez, A., Hernández-Allés, S., Martínez-Martínez, L., Benedí, V. J. & Albertí, S. (1999). Identification and characterization of a new porin gene of Klebsiella pneumoniae: its role in β-lactam antibiotic resistance. J Bacteriol 181, 2726-2732.
13. Doménech-Sánchez, A., Pascual, A., Suárez, A. I., Alvarez, D., Benedí, V. J. & Martínez-Martínez, L. (2000). Activity of nine antimicrobial agents against clinical isolates of Klebsiella pneumoniae producing extended-spectrum β-lactamases and deficient or not in porins. J Antimicrob Chemother 46, 858-860.
14. Doménech-Sánchez, A., Martínez-Martínez, L., Hernández-Allés, S., del Carmen Conejo, M., Pascual, A., Tomás, T. M., Albertí, S. & Benedí, V. J. (2003). Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance. Antimicrob Agents Chemother 47, 3332-3335.
15. Elliott, E., Brink, A. J., van Greune, J., Els, Z., Woodford, N., Turton, J., Warner, M. & Livermore, D. M. (2006). In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum β-lactamase. Clin Infect Dis 42, e95-e98.
16. Hernández-Allés, S., Albertí, S., Alvarez, D., Doménech-Sánchez, A., Martínez-Martínez, L., Gil, J., Tomás, J. M. & Benedí, V. J. (1999a). Porin expression in clinical isolates of Klebsiella pneumoniae. Microbiology 145, 673-679.
17. Hernández-Allés, S., Benedí, V. J., Martínez-Martínez, L., Pascual, A., Aguilar, A., Tomás, J. M. & Albertí, S. (1999b). Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes. Antimicrob Agents Chemother 43, 937-939.
18. Jacoby, G. A., Mills, D. M. & Chow, N. (2004). Role of β-lactamases and porins in resistance to ertapenem and other β-lactams in Klebsiella pneumoniae. Antimicrob Agents Chemother 48, 3203-3206.
19. ACT-1 β-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin PhoE. Antimicrob Agents Chemother 50, 3396-3406.
20. Landman, D., Bratu, S., Kochar, S., Panwar, M., Trehan, M., Doymaz, M. & Quale, J. (2007). Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY. J Antimicrob Chemother 60, 78-82. (Pubitemid 47073279)
21. Martínez-Martínez, L., Hernández-Allés, S., Albertí, S., Tomás, J. M., Venedi, V. J. & Jacoby, G. A. (1996). In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins. Antimicrob Agents Chemother 40, 342-348.
22. Martínez-Martínez, L., Pascual, A., Hernández- Allés, S., Alvarez-Díaz, D., Suárez, A. I., Tran, J., Benedí, V. J. & Jacoby, G. (1999). Roles of β-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob Agents Chemother 43, 1669-1673.
23. Mena, A., Plasencia, V., García, L., Hidalgo, O., Ayestarán, J. I., Albertí, S., Borrell, N., Pérez, J. L. & Oliver, A. (2006). Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development. J Clin Microbiol 44, 2831-2837. (Pubitemid 44228577)
24. Nikaido, H. (1996). Multidrug efflux pumps of Gram-negative bacteria. J Bacteriol 178, 5853-5859.
25. Paterson, D. L., Hujer, K. M., Hujer, A. M., Yeiser, B., Bonomo, M. D., Rice, L. B., Bonomo, R. A. & the International Klebsiella Group (2003). Extended-spectrum β-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type β-lactamases. Antimicrob Agents Chemother 47, 3554-3560. (Pubitemid 37345719)
26. Queenan, A. M. & Bush, K. (2007). Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 20, 440-458.
27. Sambrook, J. & Russell, D. W. (2001). Molecular Cloning: a Laboratory Manual, 3rd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
28. Tenover, F. C., Kalsi, R. K., Williams, P. P., Carey, R. B., Stocker, S., Lonsway, D., Rasheed, J. K., Biddle, D. W., McGowan, J. E., Jr & Hanna, B. (2006). Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg Infect Dis 12, 1209-1213.
29. Woodford, N., Tierno, P. M., Jr, Young, K., Tysall, L., Palepou, M.-F. I., Ward, E., Painter, R. E., Suber, D. F., Shungu, D. & other authors (2004). Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A β-lactamase, KPC-3, in a New York Medical Center. Antimicrob Agents Chemother 48, 4793-4799. (Pubitemid 39577686)
30. Woodford, N., Dallow, J. W. T., Hill, R. L. R., Palepou, M.-F. I., Pike, R., Ward, M. E., Warner, M. & Livermore, D. M. (2007). Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory. Int J Antimicrob Agents 29, 456-459. (Pubitemid 46349596)
31. Yigit, H., Queenan, A. M., Anderson, G. J., Doménech- Sánchez, A., Biddle, J. W., Steward, C. D., Albertí, S., Bush, K. & Tenover, F. C. (2001). Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45, 1151-1161. (Pubitemid 32230996)